Vials of monkeypox vaccine provided at no cost for projects seeking to address vaccination disparities among one or more priority population groups most affected by monkeypox.
Use the contact form at the bottom of the program website.
The Centers for Disease Control and Prevention will provide vials of monkeypox vaccine provided at no cost for projects seeking to address vaccination disparities among one or more priority population groups most affected by monkeypox.
Projects should make dedicated efforts to reach populations who face barriers to awareness, education, and prevention measures like vaccination. Barriers could include differences in language, location of vaccination sites, vaccine hesitancy, mistrust of government, and lack of access to online scheduling technology. Additionally, affected individuals may avoid accessing vaccination at events oriented toward specific sexual or gender identities or sexual activity out of fear of being stigmatized.
Project examples include:
Eligible applicants include:
10,000 vials of vaccine (enough for up to 50,000 intradermal doses) have been set aside for the pilot program. CDC recommends requesting up to 100 vials (300–500 doses) up front per project.
All proposals must be submitted through state or territorial health departments, tribal governments, federally funded tribal healthcare facilities, or cities currently receiving monkeypox vaccines through the SNS. Organizations interested in applying should reach out to their submitting jurisdiction.
Use the contact form at the bottom of the program website to request information on the submitting jurisdiction.